WeChat 'Yueya' app support for people on maintenance hemodialysis
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
This project will test whether the 'Yueya' mini-program on WeChat helps people on maintenance hemodialysis follow treatment, feel better, and have fewer complications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 392 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | First Affiliated Hospital of Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing, Chongqing Municipality) |
| Trial ID | NCT07291154 on ClinicalTrials.gov |
What this trial studies
This interventional trial randomizes maintenance hemodialysis patients to receive routine care or additional APP-based management delivered via the 'Yueya' mini-program on WeChat, which provides personalized health education, diet and exercise guidance, medication reminders, and condition monitoring. Clinical and laboratory indicators, cardiovascular events, hospitalizations, death, treatment compliance, and patient-reported quality of life will be recorded and compared between groups. The intervention aims to strengthen quality control in the hemodialysis unit and improve individual prognosis through enhanced self-management and clinician oversight. The study is conducted at The First Affiliated Hospital of Chongqing Medical University.
Who should consider this trial
Good fit: Adults 18–75 with stage 5 chronic kidney disease receiving regular maintenance hemodialysis (three times weekly for >3 months), who are relatively stable, able to self-care, and can use WeChat and the 'Yueya' mini-program.
Not a fit: Patients with recent major cardiovascular or cerebrovascular events, severe liver disease, active tuberculosis or AIDS, communication or cognitive barriers, or who cannot or will not use WeChat are unlikely to benefit from this app-based approach.
Why it matters
Potential benefit: If successful, the app-based program could improve treatment adherence, quality of life, and reduce hospitalizations and cardiovascular events for people on maintenance hemodialysis.
How similar studies have performed: Other digital health and app-based interventions in dialysis populations have shown improvements in adherence and quality of life in some trials, but results have been mixed and this specific 'Yueya' approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years old, and have regular dialysis three times a week. * Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study. * Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study. Exclusion Criteria: * Patients with communication barriers or other conditions that prevent them from cooperating with the study. * Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months. * Patients who are not willing to actively cooperate with the study. * Patients with severe liver cirrhosis, active tuberculosis and AIDS.
Where this trial is running
Chongqing, Chongqing Municipality
- The First Affiliated Hospital of Chongqing Medical University — Chongqing, Chongqing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Yunfeng Xia Dr
- Email: yunfengxia0920@126.com
- Phone: 86-023-89012687
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.